Drug Regulation

Novartis’ Gleevec Patent Challenged in the US?

With characteristic flair, CH Unnikrishnan of Livemint is again the first to unearth this interesting story: “US drugs regulator food and drug administration (FDA) has accepted a generic challenge by India’s Sun Pharmaceuticals Industries Ltd against Glivec, a controversial mega-earner cancer drug of Novartis AG, potentially weakening the Swiss drug maker’s petition against an Indian ruling denying the drug a patent. The challenge in the US, if it invalidates Novartis’ patent, will not only significantly stre-ngthen the plea of local…

Read More »

CIPLA Milking Indian Consumers? Charity Does Not Begin at Home!

They say “charity” begins at home. If a recent news item is to believed, then CIPLA is doing exactly the opposite!! It has donned the mantle of being a charitable messiah in parts of the world like Africa by supplying cheap AIDS medicines–whilst at the same time over-charging its Indian consumers! The Hindu Reports that: “Drug-maker Cipla has received a Government notice demanding Rs 24.23 crore, inclusive of interest for alleged overcharging by the company on antibiotic ciprofloxacin during the…

Read More »


SpicyIP had posted a couple of weeks ago, on the first case of copyright infringement against Google’s U-Tube in India. The plaintiffs in this case are T-Series a company which grew in the face of a daunting monopoly (of HMV) because of its daring, pro-active approach to copyright law. Google itself is a veteran of several such battles on the IP front in the Western world. Google News, Google Image Search, Google Book Search Project, Google Search Engine have all…

Read More »

SpicyIP Tidbits

1. “Geographical Indication” (GI) Application for “Darjeeling” in Europe: The Eco Times reports that: “The Tea Board of India filed an application here Monday to register Darjeeling as a Geographical Indication (GI) in the European Union (EU). GI is a sign used on products, which have a specific geographical origin. The use of a GI often acts as a certification that the product possesses certain qualities, or enjoys a certain reputation, due to its geographical origin. Darjeeling was the first…

Read More »

SpicyIP Events

1. India R&D 2007: December 5-6, 2007 at FICCI, Auditorium, New Delhi. See here for more details of this FICCI conference. Abstract below: After the success of the last two global conferences organized in Delhi on India R&D 2005 and India R&D 2006.FICCI in partnership with the Department of Science and Technology (DST) and Council of Scientific and Industrial Research (CSIR) is organizing the Third Global Conference on “India R&D 2007- Innovation, Advantage India” on The objective of the conference…

Read More »
Innovation Patent

Moving towards the Nano Age

Heralding the arrival of the fist wave of Nano therapeutics, India begins its tryst with the ‘Science of Minuscule’. Indian innovation as large in its prowess in the field of Biomed is all set to usher in the Nano Medical era-one that is likely to be as promising and challenging. In January this year, Dabur Pharma launched a novel nanotechnology-based drug delivery system, Nanoxel, for the anti-cancer drug Paclitaxel. This nanoscale drug delivery system is India‘s first indigenously developed nanotechnology…

Read More »

SpicyIP Jobs and Fellowships

1. Leading UK law firm seeks Patent Attorney in Singapore The successful candidate will be involved in a wide range of work and will also be involved in the strategic direction of the patent practice. This role requires drafting of patent specifications, advise on filing and protection strategies, patent audits and supervising the drafting work of a team of patent engineers. The ideal candidate should have a degree in the field of Electrical / Electronics Engineering with patent prosecution experience…

Read More »
Geographical Indication Trademark

Geographical Indications and Certification Trademarks – same difference?

The TRIPs agreement deals with Geographical Indications under Articles 22-24 and requires that each member country put in place a system to protect Geographical Indications. As per the TRIPs agreement, Geographical indications are, …, indications which identify a good as originating in the territory of a Member, or a region or locality in that territory, where a given quality, reputation or other characteristic of the good is essentially attributable to its geographical origin. The TRIPs Agreement requires that each member…

Read More »

Spicy Tidbits

Prof. Samir K Brahmachari appointed new CSIR Director General Professor Samir K. Brahmachari took charge as the new director-general of the Council of Scientific and Industrial Research (CSIR) on Monday. Prior to this appointment, Prof. Brahmachari was the director of the Institute of Genomics and Integrative Biology (IGIB). See Full Report Here. Novartis, Glivec and the IPAB: Who cares about Statutory law? This Tuesday, the Madras High Court accepted a formula proposed by the government, under which the patent appeal…

Read More »
Geographical Indication

G.Is’ as a tool towards Socio-Economic Development

  The session of the WTO Council for Trade-related Aspects of Intellectual Property Rights convened (TRIPS), on the 23-24th of October saw the group of least-developed countries come out in support of a proposal to amend TRIPS rules to require patent applicants to disclose the origin of genetic resources or traditional knowledge used in their inventions. Also widely discussed was the application of IPRs and more specifically the potential of employing the G.I right’ as a tool for advancing socio-economic…

Read More »